| UniProt ID | TAF4B_HUMAN | |
|---|---|---|
| UniProt AC | Q92750 | |
| Protein Name | Transcription initiation factor TFIID subunit 4B | |
| Gene Name | TAF4B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 862 | |
| Subcellular Localization | Nucleus . Cytoplasm . Export into the cytoplasm is mediated by a CRM1-independent nuclear export pathway and not by phosphorylation. | |
| Protein Description | Cell type-specific subunit of the general transcription factor TFIID that may function as a gene-selective coactivator in certain cells. TFIID is a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. TAF4B is a transcriptional coactivator of the p65/RELA NF-kappa-B subunit. Involved in the activation of a subset of antiapoptotic genes including TNFAIP3. May be involved in regulating folliculogenesis. Through interaction with OCBA/POU2AF1, acts as a coactivator of B-cell-specific transcription. Plays a role in spermiogenesis and oogenesis.. | |
| Protein Sequence | MPAGLTEPAGAAPPAAVSASGTVTMAPAGALPVRVESTPVALGAVTKAPVSVCVEPTASQPLRSPVGTLVTKVAPVSAPPKVSSGPRLPAPQIVAVKAPNTTTIQFPANLQLPPGTVLIKSNSGPLMLVSPQQTVTRAETTSNITSRPAVPANPQTVKICTVPNSSSQLIKKVAVTPVKKLAQIGTTVVTTVPKPSSVQSVAVPTSVVTVTPGKPLNTVTTLKPSSLGASSTPSNEPNLKAENSAAVQINLSPTMLENVKKCKNFLAMLIKLACSGSQSPEMGQNVKKLVEQLLDAKIEAEEFTRKLYVELKSSPQPHLVPFLKKSVVALRQLLPNSQSFIQQCVQQTSSDMVIATCTTTVTTSPVVTTTVSSSQSEKSIIVSGATAPRTVSVQTLNPLAGPVGAKAGVVTLHSVGPTAATGGTTAGTGLLQTSKPLVTSVANTVTTVSLQPEKPVVSGTAVTLSLPAVTFGETSGAAICLPSVKPVVSSAGTTSDKPVIGTPVQIKLAQPGPVLSQPAGIPQAVQVKQLVVQQPSGGNEKQVTTISHSSTLTIQKCGQKTMPVNTIIPTSQFPPASILKQITLPGNKILSLQASPTQKNRIKENVTSCFRDEDDINDVTSMAGVNLNEENACILATNSELVGTLIQSCKDEPFLFIGALQKRILDIGKKHDITELNSDAVNLISQATQERLRGLLEKLTAIAQHRMTTYKASENYILCSDTRSQLKFLEKLDQLEKQRKDLEEREMLLKAAKSRSNKEDPEQLRLKQKAKELQQLELAQIQHRDANLTALAAIGPRKKRPLESGIEGLKDNLLASGTSSLTATKQLHRPRITRICLRDLIFCMEQEREMKYSRALYLALLK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Phosphorylation | AAPPAAVSASGTVTM CCCCCEECCCCEEEE | 16.40 | 24719451 | |
| 22 | Phosphorylation | AAVSASGTVTMAPAG CEECCCCEEEECCCC | 15.42 | 24719451 | |
| 46 | O-linked_Glycosylation | PVALGAVTKAPVSVC CEEECCCCCCCEEEE | 22.43 | 30059200 | |
| 57 | Phosphorylation | VSVCVEPTASQPLRS EEEEECCCCCCCCCC | 25.99 | 28450419 | |
| 59 | Phosphorylation | VCVEPTASQPLRSPV EEECCCCCCCCCCCC | 34.51 | 28450419 | |
| 63 | Methylation | PTASQPLRSPVGTLV CCCCCCCCCCCCEEE | 45.67 | 115918121 | |
| 64 | Phosphorylation | TASQPLRSPVGTLVT CCCCCCCCCCCEEEE | 31.46 | 28450419 | |
| 68 | Phosphorylation | PLRSPVGTLVTKVAP CCCCCCCEEEEEEEC | 20.49 | 28450419 | |
| 71 | Phosphorylation | SPVGTLVTKVAPVSA CCCCEEEEEEECCCC | 23.94 | 28450419 | |
| 87 | Methylation | PKVSSGPRLPAPQIV CCCCCCCCCCCCEEE | 57.75 | 115918125 | |
| 116 | Phosphorylation | NLQLPPGTVLIKSNS CCCCCCCCEEEECCC | 20.22 | 28060719 | |
| 176 | Phosphorylation | LIKKVAVTPVKKLAQ HHHHHCCCCHHHHHC | 16.78 | 21815630 | |
| 179 | Acetylation | KVAVTPVKKLAQIGT HHCCCCHHHHHCCCC | 43.18 | 25953088 | |
| 230 | Phosphorylation | KPSSLGASSTPSNEP CHHHCCCCCCCCCCC | 32.71 | 25627689 | |
| 231 | Phosphorylation | PSSLGASSTPSNEPN HHHCCCCCCCCCCCC | 43.75 | 25627689 | |
| 232 | Phosphorylation | SSLGASSTPSNEPNL HHCCCCCCCCCCCCC | 28.39 | 25627689 | |
| 252 | Phosphorylation | AAVQINLSPTMLENV EEEEEECCHHHHHHH | 17.52 | 25627689 | |
| 308 | Phosphorylation | EEFTRKLYVELKSSP HHHHHHHHHHECCCC | 8.56 | 22461510 | |
| 313 | Phosphorylation | KLYVELKSSPQPHLV HHHHHECCCCCCCCH | 60.93 | 25159151 | |
| 314 | Phosphorylation | LYVELKSSPQPHLVP HHHHECCCCCCCCHH | 26.43 | 25159151 | |
| 368 | Phosphorylation | VTTSPVVTTTVSSSQ EECCCEEEEEECCCC | 19.58 | 27282143 | |
| 374 | Phosphorylation | VTTTVSSSQSEKSII EEEEECCCCCCCEEE | 30.16 | 27282143 | |
| 376 | Phosphorylation | TTVSSSQSEKSIIVS EEECCCCCCCEEEEE | 49.27 | 27282143 | |
| 383 | O-linked_Glycosylation | SEKSIIVSGATAPRT CCCEEEEECCCCCCE | 16.58 | 30059200 | |
| 395 | Phosphorylation | PRTVSVQTLNPLAGP CCEEEEEECCCCCCC | 26.75 | - | |
| 434 | Phosphorylation | GTGLLQTSKPLVTSV CCCCCCCCCCCEEEE | 21.22 | 24719451 | |
| 489 | O-linked_Glycosylation | PSVKPVVSSAGTTSD CCCCCEECCCCCCCC | 18.07 | 20068230 | |
| 489 | O-linked_Glycosylation | PSVKPVVSSAGTTSD CCCCCEECCCCCCCC | 18.07 | 30059200 | |
| 502 | Phosphorylation | SDKPVIGTPVQIKLA CCCCCCCCCEEEEEC | 14.79 | 25159151 | |
| 516 | Phosphorylation | AQPGPVLSQPAGIPQ CCCCCCCCCCCCCCC | 34.06 | - | |
| 544 | Phosphorylation | GGNEKQVTTISHSST CCCCEEEEEEECCCE | 18.87 | 29978859 | |
| 545 | Phosphorylation | GNEKQVTTISHSSTL CCCEEEEEEECCCEE | 22.94 | 29978859 | |
| 547 | Phosphorylation | EKQVTTISHSSTLTI CEEEEEEECCCEEEE | 18.41 | 29978859 | |
| 549 | Phosphorylation | QVTTISHSSTLTIQK EEEEEECCCEEEEEE | 20.44 | 29978859 | |
| 550 | Phosphorylation | VTTISHSSTLTIQKC EEEEECCCEEEEEEC | 23.24 | 29978859 | |
| 551 | Phosphorylation | TTISHSSTLTIQKCG EEEECCCEEEEEECC | 30.82 | 29978859 | |
| 553 | O-linked_Glycosylation | ISHSSTLTIQKCGQK EECCCEEEEEECCCE | 22.81 | 30059200 | |
| 553 | Phosphorylation | ISHSSTLTIQKCGQK EECCCEEEEEECCCE | 22.81 | 29978859 | |
| 561 | O-linked_Glycosylation | IQKCGQKTMPVNTII EEECCCEEECCCEEE | 20.86 | 30059200 | |
| 561 | Phosphorylation | IQKCGQKTMPVNTII EEECCCEEECCCEEE | 20.86 | 20068231 | |
| 566 | Phosphorylation | QKTMPVNTIIPTSQF CEEECCCEEEECCCC | 22.10 | 20068231 | |
| 570 | Phosphorylation | PVNTIIPTSQFPPAS CCCEEEECCCCCCHH | 25.42 | 20068231 | |
| 570 | O-linked_Glycosylation | PVNTIIPTSQFPPAS CCCEEEECCCCCCHH | 25.42 | 30059200 | |
| 571 | Phosphorylation | VNTIIPTSQFPPASI CCEEEECCCCCCHHH | 25.19 | 20068231 | |
| 571 | O-linked_Glycosylation | VNTIIPTSQFPPASI CCEEEECCCCCCHHH | 25.19 | 30059200 | |
| 577 | Phosphorylation | TSQFPPASILKQITL CCCCCCHHHEEECCC | 33.94 | 24719451 | |
| 595 | Phosphorylation | KILSLQASPTQKNRI EEEEEECCHHCHHHH | 18.60 | 25159151 | |
| 597 | Phosphorylation | LSLQASPTQKNRIKE EEEECCHHCHHHHHH | 50.08 | 30108239 | |
| 599 | Ubiquitination | LQASPTQKNRIKENV EECCHHCHHHHHHHH | 51.15 | - | |
| 670 | Ubiquitination | RILDIGKKHDITELN HHHHHCHHCCCHHCC | 41.10 | - | |
| 731 | Ubiquitination | SQLKFLEKLDQLEKQ HHHHHHHHHHHHHHH | 60.56 | - | |
| 799 | Ubiquitination | AAIGPRKKRPLESGI HHCCCCCCCCCHHCC | 61.60 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TAF4B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TAF4B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF4B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TF65_HUMAN | RELA | physical | 9724652 | |
| TAF1_HUMAN | TAF1 | physical | 15601843 | |
| TAF12_HUMAN | TAF12 | physical | 15601843 | |
| TF2AA_HUMAN | GTF2A1 | physical | 15601843 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615841 | Spermatogenic failure 13 (SPGF13) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-595, AND MASSSPECTROMETRY. | |